RPR (Diagnosis) with Reflex to Titer and Confirmatory Testing

Overview

The Rapid Plasma Reagin (RPR) test with reflex to titer and confirmatory testing is a comprehensive screening and diagnostic approach for detecting syphilis, a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum^[1]. This test identifies non-specific antibodies in the blood that may indicate active or recent syphilis infection^[2]. The reflex testing protocol ensures accurate diagnosis by automatically performing additional confirmatory tests when initial results are positive, reducing false positives and providing a definitive diagnosis^[3].

Scientific Background

The RPR test is a non-treponemal serologic test that detects reagin antibodies—non-specific antibodies produced in response to syphilis infection^[4]. When Treponema pallidum infects the body, it damages cells and triggers the immune system to produce these reagin antibodies, which react with cardiolipin antigens present in the test reagent^[5]. The RPR assay uses a mixture containing cholesterol, cardiolipin, and lecithin to detect these antibodies through a flocculation reaction^[4]. The reflex protocol automatically proceeds to titer testing if the initial screen is positive, quantifying the antibody level. If results remain unclear, confirmatory treponemal tests such as enzyme immunoassay (EIA), chemiluminescence immunoassay (CIA), or Treponema pallidum particle agglutination (TP-PA) are performed to confirm true infection versus false positives^[3].

Measurement and Testing

The RPR test is performed using a macroscopic screening assay with unheated serum^[5]. A 0.05 mL drop of serum is placed on a circle within a testing card, and reagin reacts with nontreponemal antigen containing colloidal charcoal particles, resulting in visual flocculation of black particles against a white card background^[5]. The RPR test is preferred as a first-line screening method because it is faster and easier to perform than the VDRL (Venereal Disease Research Laboratory) test^[3]. Blood samples should be collected in serum separator tubes without anticoagulants, and serum should be centrifuged and removed from the clot as soon as possible^[6]. The reflex protocol automatically triggers titer testing if the initial screen is reactive, and confirmatory testing proceeds if needed to differentiate true infection from false positives^[3].

Reference Ranges and Interpretation

RPR results are reported as either reactive (positive) or non-reactive (negative)^[2]. When the initial RPR screen is reactive, a titer is automatically performed to quantify the level of antibodies, typically reported as dilutions such as 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, or higher^[5]. A non-reactive RPR test suggests the absence of syphilis infection^[2]. However, a positive RPR result requires confirmatory testing because false positives can occur due to systemic lupus erythematosus, leprosy, brucellosis, atypical pneumonia, typhus, yaws, pinta, or pregnancy^[3]. If confirmatory treponemal testing is positive, this indicates active or recent syphilis infection. If confirmatory testing is negative, the initial positive RPR is interpreted as a false positive result^[5]. A fourfold increase in RPR titer in a previously treated patient suggests a new syphilis infection^[2].

High Values (Reactive Results)

A reactive RPR test indicates the presence of reagin antibodies and suggests possible syphilis infection^[1]. The RPR assay demonstrates 86% sensitivity in primary syphilis, 73% sensitivity in latent syphilis, and 100% sensitivity in secondary syphilis^[4]. Higher titers generally correlate with active infection, while lower titers may indicate treated or late-stage disease^[5]. Reactive results require confirmatory testing to establish a definitive diagnosis, as false positives can occur in various conditions including autoimmune diseases, infections, and pregnancy^[3]. If confirmed positive, syphilis can progress through primary, secondary, latent, and tertiary stages, with tertiary syphilis potentially causing serious cardiac and neurologic complications that may be fatal^[4]. In pregnant women, untreated syphilis can transmit to the fetus, causing congenital syphilis with severe consequences for the developing baby^[2].

Low Values (Non-Reactive Results)

A non-reactive RPR test suggests the absence of current syphilis infection or indicates that a previous infection has been successfully treated^[2]. However, non-reactive results do not completely rule out syphilis in all circumstances. During the very early stages of primary syphilis (before antibodies develop), the RPR test may be negative despite active infection—a phenomenon known as the window period^[4]. Additionally, in late latent or tertiary syphilis, some patients may have negative or weakly reactive RPR results while still harboring infection^[4]. If clinical suspicion for syphilis remains high despite a non-reactive RPR, repeat testing or alternative diagnostic methods such as darkfield microscopy in early stages may be warranted^[3]. A non-reactive result in a patient with a history of syphilis treatment indicates successful eradication of the infection^[2].

Improving Results and Management

The primary intervention for reactive RPR results is antibiotic treatment, typically with penicillin, which is the first-line therapy for syphilis at all stages^[4]. Following successful treatment, RPR titers typically decrease over a period of months to years, making RPR monitoring an effective tool for assessing treatment response^[5]. Prevention of syphilis infection involves practicing safe sex, including consistent condom use, though condoms do not protect against sores outside the condom area^[2]. Regular screening is recommended for sexually active individuals, particularly those with HIV/AIDS (at least annually), those with multiple sex partners or unprotected sex (every 3 to 6 months), and high-risk populations including sex workers, men who have sex with men, and incarcerated individuals^[2]. Routine syphilis screening during pregnancy is essential to prevent congenital syphilis transmission^[2]. Partner notification and treatment are critical components of syphilis management to prevent reinfection and continued transmission^[4].

Importance of Tracking

Regular RPR testing is crucial for early detection and treatment of syphilis, preventing progression to secondary, latent, and tertiary stages with potentially fatal cardiac and neurologic complications^[4]. The reflex testing protocol with confirmatory testing ensures accurate diagnosis and reduces unnecessary treatment of false positives, improving clinical decision-making^[3]. In pregnant women, RPR screening is vital for detecting and treating syphilis before transmission to the fetus occurs, preventing congenital syphilis and its serious health consequences^[4]. Monitoring RPR titers in treated patients helps assess treatment effectiveness and detect potential reinfection, guiding ongoing management decisions^[5]. The Centers for Disease Control and Prevention (CDC) recommends non-treponemal tests like RPR as first-line screening for syphilis, making this test a cornerstone of STI prevention and public health efforts^[4].

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.